This closely corresponds to the 35 and 24% of IgA2 plasmocytes in jejunal mucosa and peripheral lymph nodes, respectively. (b) For each protein, a relative coefficient of excretion (RCE) was calculated (jejunum to serum concentration ratio expressed relative to that of albumin). RCEs of 1.41 for orosomucoid, 1.0 for albumin, 0.83 for IgG, and 0.74 for IgE and, in the deficient patient, of 0.64 for m-IgA and 0.016 for IgM were obtained. This was inversely related to the molecular weight of these proteins and indicated their predominantly passive transport into the jejunum.
Introduction
The parameters of secretion of Ig and plasma proteins from intestinal mucosa are still poorly characterized. Most plasma proteins are believed to reach the gut lumen as a result ofpassive leakage from lamina propria capillaries (1) . In addition, other mechanisms such as local protein synthesis in the gut lamina propria and receptor-mediated active transepithelial transport also contribute to the secretion of some proteins. This is well documented for polymeric IgA (p-IgA)' and IgM (2) (3) (4) (5) (6) . However, the respective contributions of plasma IgA vs. gut-synthesized IgA are still unknown.
The intestinal lamina propria is populated by a wealth of plasmocytes, of which 80% produce IgA and 15% produce IgM (7, 8) . Over half of this IgA is in polymeric form (9) (10) (11) , and -35% ofit is IgA2 (12). In contrast, plasma IgA is predominately monomeric (m-IgA), and of the IgA I subclass (5, 13) , and is mostly produced in the bone marrow (I 1, 14) . Only p-IgA (and IgM), which is locally produced or comes from plasma (12%) (13) , has a high affinity for the secretory component (SC) (15, 16) , which is a glycoprotein that acts on the basolateral membrane of epithelial cells as a transmembrane receptor for polymeric Ig (17) (18) (19) . The SC initiates the active translocation of p-IgA and IgM across the epithelial cells from the lamina propria to the gut lumen (3, 4, 19) . So far, the transport of p-IgA from plasma into intestinal secretions has not been studied.
Therefore, this study analyzes the jejunal secretion rate of IgA and of other plasma proteins and pays particular attention to the different molecular sizes (m-and p-), subclasses (IgA 1 and IgA2), and origins of IgA. Pure jejunal secretions were collected by segmental perfusion of the gut, which thus avoided protein and proteolytic enzyme contamination. The transport rate of p-IgA from plasma into the jejunum and the contribution of plasma p-IgA to the total jejunal p-IgA were assessed radioisotopically. We also studied a patient who was totally deficient in IgA and IgM plasmacytes in the jejunal lamina propria. In this individual, it was assumed that all IgA and IgM present in the gut lumen was of plasma origin.
Methods
Subjects 12 subjects (eight caucasians and four blacks; ten males and two females) with a mean age of 40 yr (28-52 yr) were included in the study. They comprised 11 controls with a normal gastrointestinal status and one patient who lacked IgA-and IgM-containing plasma cells in the jejunal lamina propria.
Controls. The control group included two healthy volunteers and nine patients who were referred to the Hospital Saint-Lazare because ofcryptogenic abdominal complaints. After complete investigation, which included jejunal biopsy, none ofthese patients showed evidence oforganic gastrointestinal or immunological abnormality. All these individuals were submitted to jejunal perfusion. Jejunal biopsy was obtained after perfusion under endoscopic control. Two of these patients were also injected intravenously with [5] [6] [7] [8] [9] [10] 
Jejunal perfusion
Segmental perfusion of the jejunum (20, 21) was performed according to Rambaud et al. (22) , using a four-lumen tube. The tube was comprised of a proximal segment that had a lumen opening in the duodenum, an inflatable balloon that was able to occlude the duodeno-jejunal junction, a distal segment with an upper infusion point, and a distal collection point that was 40 cm below the infusion point. The tube was set in place 16 h before the perfusion. The infusion point was located near the duodeno-jejunal junction by using fluoroscopic control just before perfusion. The gut was perfused with a 115 mM NaCl, 10 mM KCI, and 35 mM mannitol solution that was supplemented with polyethyleneglycol 4,000 (PEG) (Ig/l), at a rate of 10 ml/min. In order to rinse the secretions that were present in the jejunal lumen, a 60-min equilibration period was allowed after the inflation of the balloon with 50-80 ml of air. After the equilibration period, four 20-min samples were collected by continuous free siphoning and kept at 4°C. 1 mM diisopropylfluorophosphate, a potent serine protease inhibitor, was added to each sample. A serum sample was obtained from each patient after the second 20-min period. Serum and perfusate samples were stored at -200C.
During the perfusion, duodenal contents were continuously collected and discarded. Contamination of the jejunal samples by duodenal fluids bypassing the balloon was controlled by using two semiquantitative methods: detection ofbromosulfophtalein, which was infused above the balloon into the duodenum, and detection of chymotrypsin or lipase activity in perfusates. Five 20-min samples from three patients were excluded after detection. Absence of blood contamination was confirmed in all samples (Hemotest, Ames, France).
Protein concentrations in serum and jejunal perfusate. In general, the protein concentrations in serum and jejunal samples were measured using the same methods, reagents, and standards as described by Delacroix et al. (23) . Specific concentrations of albumin (Alb), transferrin, IgG, IgA, and IgM in serum were measured by immunonephelometry (24) . IgA in the serum of the deficient patient, a2-macroglobulin (a2M), and orosomucoid (ORO) in all sera, and all proteins in jejunal samples, including SC, were measured by immunoradiometric assay (IRMA) (23, 25) . Goat serum (a2M and IgM IRMA) or horse serum (all other IRMA) were added to jejunal samples in order to keep them in a protein-rich buffer.
These aliquots were assayed at four serial dilutions (minimal dilution was 1/12.5 for a2M). Results for the dilutions falling within the standard ranges (4-100 ng/ml) always yielded curves closely parallel to the standard curves. For the deficient patient, jejunal samples were concentrated 100-fold by vacuum ultrafiltration before protein measurements. For both immunonephelometry and IRMA, the same pool of normal serum (1,000 blood donors) was used as standard.
IgE was assayed in concentrated times) intestinal fluids and in serum by particle counting immunoassay (26) . Before the assay, intestinal samples were diluted with 1 vol of normal rabbit serum to minimize the effect of protein concentration in the agglutination process, and were digested with pepsin. In 30 min, pepsin releases the Fc"-fragment (Dl -determinant) from IgE or its partially fragmented components, whereas already existing Fc-fragments are not further degraded to any major extent (27) 38 ,000 rpm (o2t = 9.11 X 10"l) on isokinetic (5-21%) sucrose gradients using the same 7S and 10.5S markers as previously described (23, 28) . The amounts of serum (4-6 Al) and secretion (50- (23) .
The proportions of free and bound SC in each perfusate sample, and the molecular size of other proteins in a 100-fold concentrated pool of perfusate samples from controls, were determined according to the same methods as for IgA. Appropriate IRMA and dilutions were used.
IgA subclasses in serum and perfusate. IgA I and IgA2 (30-32) concentrations in serum and perfusate were measured by IRMA and performed as previously described (33) , with modifications using monoclonal antibodies. Three mouse monoclonal antibodies, anti-al, anti-a2 and anti-a-chain, were obtained in our laboratory.2 Their specificity was verified by means of various highly sensitive immunoassays, using 10 human monoclonal IgA proteins of each subclass. In these preliminary experiments,2 we used both m(l) and m(2) allotypes of IgA2 (34), both isotypes of light chains, and both Fab and Fc fragments of IgAl . Antisubclass antibodies were used to coat the solid phase, and the purified anti-a-chain antibody was labeled and used as second antibody. Standards (5-150 ng/ml) were made with a serum pool of 1,000 blood donors. The pool contained 21% IgA2 and 79% IgAl, as previously measured (13, 33). The influence of the size of IgAl and IgA2 in these assays2 was also carefully assessed, using highly purified monomeric and dimeric monoclonal IgA 1 and IgA2 as controls in all assays. Results were expressed as (IgA2)/(IgAl + IgA2) X 100. The sum of(IgAl + IgA2) concentrations averaged 115±18% of total IgA concentration in serum and 94±20% in perfusate.
Immunochemistry
Jejunal biopsies were obtained in nine control patients and in the patient lacking jejunal IgA and IgM plasmocytes. To compare the IgA-subclass distribution in the jejunal lamina with that in the peripheral lymph nodes, three histologically normal lymph nodes were obtained from patients operated on for laryngeal and breast cancer.
Jejunal biopsies. In each case, five tissue samples were obtained using a forceps that was passed through an endoscope. They were fixed in Bouin's fluid, dehydrated, and embedded in paraffin within 12 h. For each patient, a standard staining procedure allowed selection of the two best-oriented specimens. Serial 3-Mm thick sections were then processed for immunohistochemistry.
Immunohistochemical procedures. Before applying antisera, all sections were incubated for 60 min with a 100 times dilution (in phosphatebuffered saline [ (13, 23, 28) . This Ig was essentially pure (28) , was not complexed to SC (28) , contained an appropriate amount of J-chain (13), was able to bind SC, and was transported at a high rate from plasma into bile of rats and rabbits (23, 35) . '3'I-albumin was purchased from Sorin Biomedica s.p.a. (Saluggia, Italia) and was homogeneous in size when submitted to SDGU. The following procedures were used to measure specific activities in serum and perfusate. Two samples of serum, obtained before and after the jejunal perfusion, were pooled. All 20-min perfusion samples were pooled after an aliquot of each had been frozen. The pools of perfusate (250 and 450 ml, respectively, in the two patients) were concentrated by vacuum ultrafiltration and adjusted to 3 ml. Radioactivities in both serum (3 ml) and concentrated perfusates (3 ml) were counted for 20 min before and after precipitation with TCA at 100 g/l final concentration. (Fig. 1 A) . The perfusate showed a major peak (80.4-97.5%, mean equals 92.5%) of 11 S and heavier p-IgA (Fig. 1 B) . SC in perfusate samples (Fig. 1 B) sedimented with p-IgA (83.3-99.3%, mean equals 91.5%) and in the 4.5S position corresponding to free SC (mean equals 8.5%). SC-free p-IgA could not be detected in the perfusate.
All other proteins studied in the perfusate (Fig. 1 C) (Fig. 3) . In the first group of proteins (Fig. 3, open columns other RCE values observed were: 1.98 for m-IgA, which was >IgG (P < 0.001), 0.77 for a2M, which was _IgG and IgE, and 6.7 for IgM and 218 for p-IgA, which was >RCEs of all other proteins of lower molecular weight (P < 0.001).
Radioisotopic studies. As shown for patient 2 in Fig. 4 Fig. 5 . In serum, p-IgA contributed 6% of total IgA, a figure slightly lower than the lowest value obtained in controls. In the perfusate, IgA resolved in a major peak of m-IgA (82%) and a minor peak of I1S p-IgA (18%). SC occurred predominantly (98%) in the free form. These profiles are in sharp contrast to those observed in controls (Fig. 1) . (Table V) were below the control range in both serum and perfusate and were similar in both fluids, which contrasted with results obtained in controls.
When the RCEs for p-IgA as well as m-IgA and IgM were calculated in this deficient individual (Table V) , values of 1.24, 0.64, and 0.016 were obtained, respectively. Thus, only p-IgA was found to be selectively transported from plasma, as compared with Alb, whereas the transport of plasma IgM appeared to be greatly affected by the molecular weight of this protein. RCE values for p-IgA and IgM were _0.5% of control values. This again indicates that in normal individuals, local production of p-IgA as well as that of IgM contributes the majority of these Ig in the jejunal lumen. Fig. 6 summarizes the RCE data that was obtained in the deficient patient, (shaded columns for mIgA, p-IgA, and IgM), in radioisotopic studies (shaded columns for Alb and p-IgA), and in controls (points). Plasma-to-jejunum transport of Alb, m-IgA, and IgM were inversely related to their molecular weights, as observed in controls for ORO, Alb, IgG, and IgE. By contrast, plasma-to-jejunum transport ofp-IgA was _-3.2 times (mean RCE in the deficient individual and in isotopic studies) more rapid than the transport of Alb, exceeding by -15 times the transport rate (RCE equals 0.2) expected from its molecular weight (see regression line). It is interesting to notice that a2M's RCE (0.77) in controls also greatly exceeded the value expected (0.02) from its molecular weight.
Discussion
This study allowed the assessment of three main parameters of protein secretion from the jejunal mucosa: the absolute protein secretion rate, the relative coefficient of protein excretion, and the relative contributions ofplasma-derived and locally produced IgA (and IgM). These parameters were characterized with greatly reduced sources of errors. The distribution of Ig-containing cells in the lamina propria of our control group was similar to that previously observed in normal individuals (8, 38) . The use of an occluding balloon in the segmental perfusion of the gut prevented contamination or reflux of the perfusate samples. In our procedure, only minor movements of water and electrolytes were induced. The artefacts, due to the occlusion of the gut lumen with alteration of gut vascularization, were found unsignificant in a preliminary study (22) . No bound to SC. SC was also present in the free form. The serum concentration of p-IgA was -50 times lower than that of IgG, whereas the p-IgA concentration in jejunal perfusates was eightfold greater than that of IgG, and usually exceeded that of Alb. This is in contrast to results of previous studies (1, 39) . In these studies, IgG and IgA concentrations in upper bowel secretions were roughly similar, and lower than that of Alb. This may have been due to a contamination with bile, which contains similar amounts of IgG and IgA and a larger amount ofalbumin (23) . The separate measurement ofm-and p-IgA, with correction for size effects in IgA IRMA, could also explain the difference between the present and previous studies (40) .
In the deficient patient, although jejunal concentrations of p-IgA and IgM were greatly reduced, SC The contributions of plasma vs. local intestinal production of IgA (and IgM) in jejunal secretions were directly investigated with radioisotopes or were derived from comparison between RCE results in the deficient patient and those obtained in controls. Calculation of the specific activities of '251_p-IgA in serum and perfusate simultaneously demonstrated that only a minority (2 and 5%) ofjejunal p-IgA is derived from plasma, vs. _100% for Alb. In the deficient patient, RCE of p-IgA was only 0.6% of the mean control value, which again indicated that in normal individuals almost all jejunal p-IgA (-98%) comes from local production in the gut wall. In the present study we calculated an RCE for plasma-to-jejunum transport ofp-IgA of -3.2 (mean from isotopic experiments and from the deficient patient). This value is close to those previously recorded for the transport of plasma p-IgA into bile (RCE equals 4.5) and into saliva (RCE equals 4.4) (23). It demonstrates a small, selective plasma-tojejunum transport of p-IgA (-5-fold more rapid than for m-IgA). Its absolute amount can be estimated at -6 mg/d or -0.08 mg/kg per d for the first 40 cm ofjejunum. This is <2% of the fraction of the intravascular pool of p-IgA that is cleared daily from plasma (4.5 mg/kg per d) (13). In the deficient patient, the RCE for m-IgA (0.6) was similar to that ofIgG and accounted for 32% ofthe mean control value. Thus m-IgA does not appear to be selectively transported across the jejunal wall, and its local production in the lamina propria probably contributes for greater than half of its total secretion. For IgM, the RCE in the deficient patient was extremely low (0.0 16), 400-fold smaller than in controls. This result indicates that the plasma-to-jejunum transport of IgM, despite the presence of epithelial SC, is dramatically affected by its molecular weight, and that local synthesis in the gut wall contributes >99% of the jejunal secretion of IgM in normal individuals.
